Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
AstraZeneca
University of Nebraska
Nagoya University
Fox Chase Cancer Center
Dana-Farber Cancer Institute